secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2022-03-10T23:59:59+00:00
Accession:  0001564590-22-009633
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo appoints Vaidehi Joshi to Board of Directors as Class I Director
-------------------------------------------------------------------------

- Appointment effective March 8, 2022; term expires at 2024 annual meeting.
- Joshi brings bioprinting and drug discovery experience from Viscient Biosciences and prior Organovo role.
- Compensation: $50,000 annual retainer (pro-rated) and initial option grant of 35,000 shares at $3.47.
- Option vests quarterly over 12 quarters; accelerated on change of control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000156459022009633/0001564590-22-009633-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000156459022009633/onvo-8k_20220308.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-009633

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer